← Back to Clinical Trials
Recruiting NCT06027671

NCT06027671 Structured Peer-delivered ART and Reentry Community Strategy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06027671
Status Recruiting
Phase
Sponsor Johns Hopkins University
Condition Retention in Care
Study Type INTERVENTIONAL
Enrollment 400 participants
Start Date 2024-11-18
Primary Completion 2028-07-31

Trial Parameters

Condition Retention in Care
Sponsor Johns Hopkins University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 400
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-11-18
Completion 2028-07-31
Interventions
Full-SPARCS Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The overarching goal of this study is to implement a transition community adherence club strategy (Full-SPARCS) for HIV-positive individuals transitioning from correctional to community settings in South Africa. The investigators seek to provide actionable findings to inform policy decisions to contribute to HIV care continuity with this population. The investigators note that effectiveness and scalability often conflict with intervention design; thus, the investigators have proposed testing whether a group approach is effective and the investigators will assess the costs of each component * To compare the effectiveness of Full-SPARCS to care as usual to achieve HIV RNA suppression 6 months following correctional facility release * To assess determinants of implementation of Full-SPARCS * To assess the scalability through costing and cost effectiveness analysis of Full-SPARCS

Eligibility Criteria

Inclusion Criteria: * Incarcerated at one of the participating study enrolment sites, awaiting trial (un-sentenced) and sentenced individuals. * Diagnosed with HIV and ART at the time of enrolment. * Anticipated release or trial date within three months of study enrolment. * Self-report expected to reside in an unrestricted environment within Ekurhuleni, Tshwane, or Johannesburg districts of Gauteng Province and within proximity to one of the SPARCS intervention sites (i.e., within 20km, 45-minute travel time, or two local taxi minibus rides) * Willing to participate in study post-release follow-up activities and provide contact information for post-release follow-up. Exclusion Criteria: * \<18 years of age. * Condition (severe cognitive dysfunction or mental illness) rendering the individual unable to provide informed consent. * Unable to provide informed consent to participate in the study. * Assessment by DCS health staff indicating that the individual requires a high intensity of c

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology